Matches in Wikidata for { <http://www.wikidata.org/entity/Q64638901> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- Q64638901 description "clinical trial" @default.
- Q64638901 description "ensayu clínicu" @default.
- Q64638901 description "klinisch onderzoek" @default.
- Q64638901 description "клінічне випробування" @default.
- Q64638901 name "A Study in Participants With Moderate to Severe Rheumatoid Arthritis" @default.
- Q64638901 type Item @default.
- Q64638901 label "A Study in Participants With Moderate to Severe Rheumatoid Arthritis" @default.
- Q64638901 prefLabel "A Study in Participants With Moderate to Severe Rheumatoid Arthritis" @default.
- Q64638901 P1050 Q64638901-4556B50A-E802-4A3E-9F12-9B31F471FA5F @default.
- Q64638901 P1132 Q64638901-3A6BA11D-3104-422E-98C4-3619A09AA5BD @default.
- Q64638901 P131 Q64638901-3273095A-D097-4FA3-967F-48EC5602E22F @default.
- Q64638901 P1476 Q64638901-BC75AC52-A150-4343-9BA7-6733AF1D7AC0 @default.
- Q64638901 P17 Q64638901-02A770EB-FFEA-4019-8409-7427F667A1B3 @default.
- Q64638901 P17 Q64638901-183ACE3B-59FD-4F5F-B36C-F73E914F4142 @default.
- Q64638901 P17 Q64638901-259B185B-A3ED-4B5B-9739-58AC8EFE0646 @default.
- Q64638901 P17 Q64638901-35EFA72E-7531-4186-A8B0-B713668AB5C5 @default.
- Q64638901 P17 Q64638901-407A8B84-AEA8-4BCA-9A04-273E8B10905E @default.
- Q64638901 P17 Q64638901-48341F07-D31E-42AB-B8CE-C337576EA40B @default.
- Q64638901 P17 Q64638901-4F4AA8D4-8915-4F55-9108-5B02D8A593A2 @default.
- Q64638901 P17 Q64638901-5AAF97DC-23AC-4AAF-B3E1-7792ACA220AE @default.
- Q64638901 P17 Q64638901-69FCD02D-B9D5-4D0E-AB0F-5657603E199D @default.
- Q64638901 P17 Q64638901-6C3B5191-4268-4970-82EA-AA6558ADBF10 @default.
- Q64638901 P17 Q64638901-7DBEBB2C-EE99-4E13-B42A-B883F3EB2007 @default.
- Q64638901 P17 Q64638901-8E1EF2B9-4DEA-403B-9BC8-376986DA4214 @default.
- Q64638901 P17 Q64638901-9E0DA7E2-AAB1-43D7-8637-96791DE8BDD1 @default.
- Q64638901 P17 Q64638901-BA4DCFB6-CB6E-4B07-8AFC-FAD483616C2F @default.
- Q64638901 P17 Q64638901-D57A79CA-7972-42F1-9010-F0E5C16CB6DB @default.
- Q64638901 P17 Q64638901-EC48B1C1-41CF-41A3-BBE0-E2497C41367B @default.
- Q64638901 P1813 Q64638901-80590D6E-3451-40F1-B3D1-2007506EE487 @default.
- Q64638901 P2899 Q64638901-B7F16FB9-8CEF-4D93-AC24-7BD3EB72DE47 @default.
- Q64638901 P3098 Q64638901-3E781951-DB6D-404F-A147-49F3A8AD4C57 @default.
- Q64638901 P31 Q64638901-16358D54-C1C0-4C1D-BE5D-E63035452585 @default.
- Q64638901 P4844 Q64638901-EB6944CF-3194-4279-81FD-22DD7957EA18 @default.
- Q64638901 P580 Q64638901-8AD2E5BE-ADFB-4A3E-BECA-CA455782A803 @default.
- Q64638901 P582 Q64638901-6AB176C1-C996-45B2-970A-E8B2A2EA369D @default.
- Q64638901 P6099 Q64638901-2FCED507-CFFC-4369-8F57-B98EE782077C @default.
- Q64638901 P8363 Q64638901-3D4EF7EB-3120-4F09-92CF-3A50D756F734 @default.
- Q64638901 P1050 Q170990 @default.
- Q64638901 P1132 "+588" @default.
- Q64638901 P131 Q1183 @default.
- Q64638901 P1476 "A Randomized, Double-Blind, Active-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs" @default.
- Q64638901 P17 Q145 @default.
- Q64638901 P17 Q155 @default.
- Q64638901 P17 Q16 @default.
- Q64638901 P17 Q17 @default.
- Q64638901 P17 Q183 @default.
- Q64638901 P17 Q258 @default.
- Q64638901 P17 Q30 @default.
- Q64638901 P17 Q31 @default.
- Q64638901 P17 Q34 @default.
- Q64638901 P17 Q38 @default.
- Q64638901 P17 Q40 @default.
- Q64638901 P17 Q41 @default.
- Q64638901 P17 Q414 @default.
- Q64638901 P17 Q45 @default.
- Q64638901 P17 Q668 @default.
- Q64638901 P17 Q96 @default.
- Q64638901 P1813 "RA-BEGIN" @default.
- Q64638901 P2899 "+18" @default.
- Q64638901 P3098 "NCT01711359" @default.
- Q64638901 P31 Q30612 @default.
- Q64638901 P4844 Q127060 @default.
- Q64638901 P580 "2012-11-01T00:00:00Z" @default.
- Q64638901 P582 "2015-02-01T00:00:00Z" @default.
- Q64638901 P6099 Q42824827 @default.
- Q64638901 P8363 Q78089383 @default.